Biomedical Catalyst 2025: Up to £25 Million for UK SMEs Developing Health Innovations

Biomedical Catalyst 2025: Industry led R&D small projects is a UK government competition for commercial health innovation teams that need early-stage R&D funding. The opportunity is for UK-based micro, small and medium-sized enterprises (SMEs) and is run by Innovate UK through the Innovation Funding Service.

This specific page is for the small projects strand: each project can have up to £1,000,000 total eligible project costs and can request up to £500,000 in grant funding, subject to the funding rates that apply to your project type and organisation type.

Important first point: the competition page currently shows this round as closed. So treat this as a planning playbook for the current closed call and for the next Biomedical Catalyst open round.

At a glance

What this call is (in plain English)

This is not a generic research grant. It is a targeted, competitive innovation fund for company-led health technology development where a viable solution exists and needs a defined de-risking step before wider funding, manufacturing, trials at scale, or investment.

The wording “industry led” is important:

• The project is expected to be driven by a business need and commercial route, not by pure academic curiosity.
• Innovation should move toward a product, platform, process, or service that can strengthen competitiveness and productivity.
• The public funding is intended to make your next development step more attractive to private capital, partners, or customers.

This differs from pure university-led grant schemes in that Innovate UK here usually expects the proposal to be anchored in a company model.

The call is split into two strands:

• Small projects (this page): grant request up to £500,000.
• Large projects: above £500,000 per project.

You must apply to the right strand, because applications are not transferred between strands.

Why companies apply for this round

SMEs usually apply when all of the following are true:

1. They have something beyond idea-stage. You can show evidence of technical proof or technical feasibility direction.
2. The missing piece is not “proof it exists somewhere in the lab” but de-risking and development toward regulation, production logic, market access, or product/system readiness.
3. They can commit organisationally and financially to cover matched funding above the grant amount.
4. They can answer a commercial story clearly: who will benefit, why now, what the go-to-market path is, and why this specific grant changes outcomes.

The competition is often used when companies need to bridge from pre-clinical validation to more commercially meaningful milestones, or from prototype to clinical feasibility, or from development concept to implementation planning for later growth funding.

Who should apply (and who should not)

The page is open to single applicants and collaborations, but the practical burden is high and many applications fail before merit review because of fit and documentation issues.

You are likely to be a good fit if:

• You are a UK-registered micro, small, or medium enterprise.
• Your project is about human health/healthcare, including therapeutics, devices, diagnostics, digital, or service innovation.
• You have a realistic project scope that can be completed within 6–24 months.
• Total eligible costs and the grant request fall inside this strand’s limits.
• You can keep the work in line with UK exploitation obligations (UK-based delivery and benefit).
• You can provide strong evidence for a real unmet need and a clear project hypothesis.

You are unlikely to be suitable if:

• You need broad “science grant” support with no commercial route.
• Your proposal is routine business activity with no R&D.
• You mainly intend to fund product roll-out already on the market.
• The work is not in human life sciences.
• You only have broad ideas and no evidence of technical or commercial feasibility.
• You cannot commit a matched funding share and a proper finance plan.

Who can be in the project team

Lead applicants:

• Must be a UK-registered micro, small, or medium-sized enterprise claiming grant in the application.

Collaborators can be one of the following types (subject to eligibility in full rules):

• business of any size
• academic institution
• charity
• not-for-profit
• public sector organisation
• research and technology organisation (RTO)

If collaborative:

• At least one partner must apply for funding, and the lead must justify the collaboration.
• The lead must not account for more than 70% of total eligible project costs.
• At least 50% of total eligible costs must be incurred by SMEs.
• Ineligible grant claims from non-funded partners are possible, but their costs can still affect the total eligible costs logic.

What the call funds

You should think of this call as funding slices of pre-market R&D rather than full commercialization. The call page lists activities such as:

• experimental evaluation at lab scale
• in vitro or in vivo studies for proof of concept/safety where appropriate
• prototyping
• production pathway exploration
• product development planning and IP actions
• demonstration of clinical utility and evidence (including early phase clinical relevance where suitable)
• regulatory planning

Funding and eligible costs in practical terms

• Total project costs cap: £1,000,000.
• Grant request cap: £500,000.
• Minimum grant request shown in competition guidance: £150,000.
• Grant is linked to categories of work:
  • Industrial research: up to 70% for micro/small, up to 60% for medium.
  • Experimental development: up to 45% for micro/small, up to 35% for medium.
  • (Different partner-specific rules can apply to large firms, research organisations, and non-economic activity participants.)

The remaining costs must be covered by the applicant organisations.

Because this funding is grant support, it is not debt and does not require equity dilution, but it does impose milestones, progress reporting, and compliance requirements before and during project set-up.

Competition design and decision logic (how assessments work)

A common misconception is that applications are judged only on whether the science is good. In these rounds, assessors score most of the application questions, and they also look at

• need/problem definition
• the innovation and technical approach
• team capability and execution
• market clarity
• route to impact and competitiveness
• costs and value for money
• risks and project management

The result is usually a competitive score-based ranking, and Innovate UK reserves the right to select based on a portfolio spread across themes, sectors, and project types. In official messaging, a typical success expectation is around 10% for similar rounds.

Even strong technical ideas can lose if one of these fails:

• Scope mismatch
• unrealistic costs or timelines
• vague commercial case
• weak explanation of why this exact project is the right next step
• incomplete partnership governance and finance completion

Eligibility checklist for this specific competition

Use this as a practical pre-application filter.

1. Is the lead applicant a UK-registered SME?
2. Is the project under human life sciences and healthcare?
3. Can total eligible costs be kept within £1,000,000?
4. Can grant request be kept within 150k–500k?
5. Is the proposal pre-market R&D, not full product commercialization?
6. Will at least 50% eligible costs be incurred by SMEs if collaborative?
7. Can the project run from start (first of month) and complete between 6–24 months?
8. Can the team complete all sections by the deadline, including partner responses?
9. Can you start within allowed window and show evidence-based feasibility?
10. Are legal/compliance issues checked, especially sanctions and animal use where relevant?

If you answer “no” to any of these, fix first or redirect to a more suitable call.

Project scope and exclusions you should respect

The competition supports health innovation across many themes, such as advanced therapies, diagnostics, medical devices and digital health, and related categories. It generally does not support:

• fundamental research only, without clear development progression
• feasibility work that has no development path
• products already on the market
• routine business spend without R&D
• projects lacking clear innovation or measurable patient/commercial impact
• projects with animal welfare issues that fail UK standards

The scheme also disallows certain prohibited subsidy conditions, for example:

• funding tied to export performance
• funding tied to mandatory domestic input use

This is standard state aid/subsidy control behavior for public innovation support, so legal checks are part of the process.

How to apply (step-by-step)

The application has four main sections.

Before you start

Before opening the application form:

• Read official Innovate UK guidance for applications.
• Check that project type and dates fit the rules.
• Decide whether you apply alone or as lead in collaboration.
• Map your cost model early so you can confirm grant match logic.
• Contact support early if needed; Innovate UK guidance says contacting support at least 15 working days before close gives the best support window.

Section 1: Project details (not scored but essential)

You need:

• project team and roles
• title, duration, start date
• research category (industrial research / experimental development)
• concise summary and public description
• explicit scope alignment

Tips:

• Keep the public description “publishable.”
• Ensure no commercially sensitive data in this section because it may be publicly visible.

Section 2: Application questions (scored)

Questions 9 onward and related scoring areas need careful evidence and structure. The page requires answers for all questions, and there are strict word limits for many questions (for example, around 400 words in several sections).

Key evidence points that usually matter most:

• clear articulation of unmet clinical/business need
• technical novelty and feasibility evidence
• IP strategy and freedom-to-operate thinking
• market evidence and customer segmentation
• go-to-market and exploitation plans
• risk register and mitigation steps
• value-for-money rationale linked to matched funding

Critical rule: do not include web links or URLs in your written answers. The official guidance says this can make an application ineligible.

Section 3: Finances

Every participating organisation usually needs to complete its own finance inputs correctly, including:

• eligible cost categories
• partner funding split
• grant claim requested
• cost split and timing assumptions
• cash-flow logic up to reimbursement if relevant

You should validate cost assumptions with clear internal budget owners and make sure claims match competition-level eligible-cost rules.

Section 4: Project impact

This section is not scored but is still required. It covers project-level impact narrative and supporting obligations.

Submission mechanics

You can reopen and resubmit after initial submission, up to the competition deadline.

Because there are multiple assignees, incomplete partner sections are a frequent cause of invalid submission, so use a pre-deadline partner checklist.

What to prepare before you write the application

Treat this as a document sprint with an owner per subsection.

Suggested evidence bundle

• one-page internal brief on problem, current stage, and value proposition
• data on prior experiments, feasibility tests, or pilot outputs
• clear budget working papers and supporting estimates
• project plan with dependencies and milestones
• partner statements and roles
• risk register draft with owners
• export control/permitting notes (if applicable)
• clinical or regulatory mapping at a high level

Collaboration readiness checklist

• Is the role of each partner needed, measurable, and non-overlapping?
• Do collaborators know they must complete finance and project impact inputs?
• Have invitation windows and account setup deadlines been built into the plan?
• Have you verified the lead does not exceed 70% of eligible costs?

How to judge whether it is worth your time

A quick “go/no-go” framework:

• Go if your team can answer all of these in draft form now:
  • problem and market evidence
  • technical evidence to show feasibility
  • clear grant-rate-compatible finance model
  • named milestones and realistic timeline
  • exploitation pathway with at least one route to investment or revenue
• Pause if you have early-stage enthusiasm but missing one of the above.
• Stop and reconsider if your proposal cannot satisfy scope, UK SME lead status, project size, or commercialization logic.

A high-quality application is usually a team effort: technical lead, business lead, finance lead, and one owner for IFS operations.

Practical 10-day style application workplan

For a tight call, use this structure (adjusted to the remaining time you have):

Four to eight weeks before the deadline

• Finalise project title, scope, and target outcome definition.
• Confirm partner composition and legal constraints.
• Draft the narrative for need, innovation, and route-to-market.
• Build initial finance table and validate against 150k/500k grant band and total-cost limits.

Two to three weeks before

• Finalize all scored question drafts.
• Add evidence references for all claims.
• Run a technical plausibility review with at least one outside reviewer.
• Confirm word limits and prohibited content constraints.

Final two weeks

• Complete partner sections.
• Test all finance calculations with internal accounts lead.
• Add appendices only where useful and within limit (10MB, usually up to two A4 pages, and PDF format rules).
• Start formal internal quality pass for clarity and consistency.

Last week

• Invite lead and collaborators to validate final submission.
• Check complete status of each section.
• Submit and re-check after any edits.
• Re-submit if you need to correct anything before deadline.

Even if the website says you can reopen after submission, do not rely on one final chance in the final hour.

Required materials and technical formatting notes

Most useful sections to have ready:

• Project description and public-facing summary
• Work packages and milestones (for project management answer)
• Budget + finance justification
• Project plan / Gantt style appendix
• Risk register appendix
• Optional support PDFs for key sections where requested (within file constraints)

The page indicates strict appendix behavior for scored responses and app workflows. Keep supporting files concise, clear, and truly evidence-anchored.

Common mistakes that reduce scoring or invalidate applications

1. Applying to the wrong strand This call is for small projects only. Over-sized funding requests above small-strand caps are not eligible.

2. Underestimating preparation for partnership logistics Collaborative applications fail if one invited partner misses finance details or partner-side sections.

3. Assuming no matching funds are required You cannot rely only on grant funding. Matched costs must be funded by the organisations involved.

4. Including URLs in answers Explicitly excluded in official guidance and can trigger ineligibility.

5. Confusing “innovation” with “nice idea” You need evidence of technical/commercial feasibility, and a path beyond a generic concept.

6. Weak commercialization logic Innovation without market strategy is treated as risky even if technically strong.

7. Ignoring prohibited funding conditions Subsidy control/state aid and sanctions-related requirements should be checked early.

8. Treating grants as a substitute for ownership, team, and operations Grant funding accelerates execution but does not replace execution capacity.

9. Missing contact timing If you need support, wait too late and you may get only minimal guidance.

10. Late submission caused by self-inflicted process issues A late submission due to local errors is rarely recoverable.

Official timeline (current round)

From the competition page:

• Competition opened: 10 November 2025
• Applicants notified: 9 April 2026 (example date shown on page)
• Project setup from: 1 June 2026
• Deadline: shown as 11 December 2025 11:00am UK time on IFS

Because the page shows the call as closed, use these dates for historical planning and benchmark.

What happens after submission

If successful

• You will receive a grant offer.
• You will move to project setup on IFS.
• UKRI checks and supporting information may be requested.
• Only after successful checks does setup complete and project implementation begin.

If unsuccessful

• Feedback is usually available via IFS portal.
• Typical reasons include scoring shortfalls, portfolio balance constraints, or scope mismatch.
• A strong application can still receive constructive feedback and is often valuable for the next round.

Applicant self-assessment: should you apply now?

Use this scorecard internally. If you score 5 or lower out of 10 on the first three categories, do not submit yet:

• Eligibility clarity
• Scope and commercial fit
• Finance and project management completeness

If you are 8+ on all three, build a second draft and run one internal review against scored questions.

FAQ (answers based on official competition guidance)

Is this only for micro and small firms?

No. Medium-sized SMEs can also apply if they meet the same SME lead rules and funding rate conditions.

Can a large company lead?

No. The lead funding applicant for this competition must be a UK-registered micro, small, or medium-sized enterprise.

What is the minimum and maximum grant amount?

The competition materials show a typical band with a minimum of £150,000 and a maximum of £500,000 request, with total eligible costs capped at £1,000,000.

Can I submit an academic-led solo application?

Academic institutions cannot lead this route as the lead applicant. They can participate as collaborators in certain forms.

Is this pre-market only?

Yes, it is targeted at pre-market R&D projects with existing feasibility evidence.

Can collaborative projects use overseas partners?

The competition allows non-funded partners from overseas in some cases, but work location, exploitations, and subcontractor justifications have specific rules. Overseas subcontractors are only acceptable with documented justification.

Do I need to avoid URLs in answers?

Yes. The competition notes that including URLs in scored answers can make the application ineligible.

Does Innovate UK advise on the exact route?

The service team provides guidance and support, but you should still verify fit before applying.

If rejected, is all lost?

No. You can use feedback, strengthen the application, and re-apply to later rounds where available.

How does this compare to private funding?

Grant support can improve investor confidence by reducing technical and execution risk, but it is not a replacement for a strong private financing strategy.

What to do next

For this round, the official status is closed.

If your profile and timeline still match the criteria, you should:

• Archive this framework and reuse it as your baseline for the next Biomedical Catalyst opening.
• Prepare a “ready-to-submit” short-form brief in your internal backlog.
• Keep finance and project milestones ready in the format above.
• Build a partner-ready list with roles and delivery dates.

If you are currently ahead of schedule, begin by drafting:

1. project summary, 2) market evidence paragraph, 3) cost model, 4) risk register.

These four pieces, prepared early, make the final submission much faster.

Official links

• IFS competition page (small projects): https://apply-for-innovation-funding.service.gov.uk/competition/2333/overview/f5431c75-e2e1-48f4-bc8e-62d52121cb6f
• UKRI opportunity page: https://www.ukri.org/opportunity/biomedical-catalyst-2025-industry-led-r-d-small-projects/
• Innovate UK application guidance: https://www.ukri.org/councils/innovate-uk/guidance-for-applicants/general-guidance/your-application/

For direct support or accessibility support, use the Innovate UK contact details published on the competition page and their support channels.